• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[治疗外周动脉疾病的推荐干预措施:让患者保持活动]

[Recommended interventions for the treatment of peripheral artery disease : Keep the patients moving].

作者信息

Krankenberg H

机构信息

Zentrum für Gefäßmedizin, Abteilung Angiologie, Asklepios Klinikum Harburg, Eißendorfer Pferdeweg 52, 21075, Hamburg, Deutschland.

出版信息

Internist (Berl). 2019 Dec;60(12):1235-1239. doi: 10.1007/s00108-019-00695-x.

DOI:10.1007/s00108-019-00695-x
PMID:31667527
Abstract

BACKGROUND

Peripheral artery disease (PAD) is often diagnosed in an advanced stage. Accordingly, revascularization is also performed late.

OBJECTIVES

In this paper, the authors describe the progression to critical limb ischemia and cardiovascular risk. Revascularization for secondary prevention is explained. Revascularization strategies according to lesion location and complexity of the stenosis or occlusion are discussed.

MATERIALS AND METHODS

The current guidelines and randomized controlled studies and meta-analyses are analyzed.

RESULTS

PAD is associated with a considerable level of suffering and a high cardiovascular risk. Up to 20% of patients with claudicants will progress to critical limb ischemia. Progression and risk of mortality increase during the course of the disease. Improvement of walking ability by revascularization is a major goal of secondary prevention. In the femoropopliteal segment, drug-coated balloon (DCB) angioplasty and bare-metal stent (BMS) implantation are the methods of choice. In long lesions, spot-stenting should be preferred. For treatment of in-stent restenosis, DCB have proven their effectiveness. In severely calcified or dissected lesions, BMS are well suited. Infrapopliteal lesions should be revascularized to provide in-line flow to the foot through the target arterial path. According to current evidence, DCB or drug-eluting stents are more effective than plain old balloon angioplasty or BMS.

摘要

背景

外周动脉疾病(PAD)常于晚期被诊断出来。因此,血管重建术也在晚期进行。

目的

在本文中,作者描述了肢体严重缺血的进展情况以及心血管风险。解释了二级预防中的血管重建术。讨论了根据病变位置以及狭窄或闭塞的复杂程度制定的血管重建策略。

材料与方法

分析当前的指南、随机对照研究以及荟萃分析。

结果

PAD与相当程度的痛苦和高心血管风险相关。高达20%的间歇性跛行患者会进展为肢体严重缺血。疾病过程中,病情进展和死亡风险会增加。通过血管重建术改善步行能力是二级预防的主要目标。在股腘动脉段,药物涂层球囊(DCB)血管成形术和裸金属支架(BMS)植入是首选方法。对于长病变,应优先选择点状支架置入术。对于支架内再狭窄的治疗,DCB已证明其有效性。在严重钙化或夹层病变中,BMS很适用。腘以下病变应进行血管重建,以通过目标动脉路径为足部提供直线血流。根据目前的证据,DCB或药物洗脱支架比普通老式球囊血管成形术或BMS更有效。

相似文献

1
[Recommended interventions for the treatment of peripheral artery disease : Keep the patients moving].[治疗外周动脉疾病的推荐干预措施:让患者保持活动]
Internist (Berl). 2019 Dec;60(12):1235-1239. doi: 10.1007/s00108-019-00695-x.
2
Critical limb ischemia update and the evolving role of drug-elution technologies.严重肢体缺血的最新进展及药物洗脱技术的不断演变作用
Expert Rev Cardiovasc Ther. 2017 Dec;15(12):891-896. doi: 10.1080/14779072.2017.1408409. Epub 2017 Nov 27.
3
Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.药物涂层球囊与药物洗脱支架治疗长股腘动脉病变的比较
J Endovasc Ther. 2014 Jun;21(3):359-68. doi: 10.1583/13-4630MR.1.
4
Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis.股腘动脉疾病中血管成形术或裸金属支架与药物洗脱血管内治疗的比较:一项系统评价和荟萃分析。
J Cardiovasc Surg (Torino). 2019 Oct;60(5):546-556. doi: 10.23736/S0021-9509.19.11115-9. Epub 2019 Sep 13.
5
Optical coherence tomography: guided therapy of in-stent restenosis for peripheral arterial disease.光学相干断层扫描:外周动脉疾病支架内再狭窄的引导治疗
J Cardiovasc Surg (Torino). 2017 Aug;58(4):518-527. doi: 10.23736/S0021-9509.17.09946-3. Epub 2017 Apr 4.
6
Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds.晚期外周动脉疾病管理的新方法:药物涂层球囊、药物洗脱支架及生物可吸收支架的前景
Curr Cardiol Rep. 2015 Sep;17(9):624. doi: 10.1007/s11886-015-0624-6.
7
Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.药物涂层球囊血管成形术治疗股腘段支架内再狭窄。
Circ Cardiovasc Interv. 2018 Dec;11(12):e007055. doi: 10.1161/CIRCINTERVENTIONS.118.007055.
8
Systematic review and meta-analysis of balloon angioplasty versus primary stenting in the infrapopliteal disease.膝下疾病中球囊血管成形术与直接支架置入术的系统评价和荟萃分析。
Vasc Endovascular Surg. 2014 Jan;48(1):18-26. doi: 10.1177/1538574413510626. Epub 2013 Nov 7.
9
Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?药物洗脱支架用于治疗腹股沟下动脉疾病的血管内治疗是否比单纯血管成形术或联合裸金属支架治疗效果更好?
Interact Cardiovasc Thorac Surg. 2014 Aug;19(2):282-5. doi: 10.1093/icvts/ivu093. Epub 2014 Apr 11.
10
Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).肝素结合涂层支架与裸金属支架治疗复杂股腘动脉病变的随机对照试验(Viabahn 覆膜支架联合 PROPATEN 生物活性表面[VIA]与裸钽支架治疗股浅动脉闭塞性疾病长段病变的疗效比较[VIASTAR 试验])。
J Am Coll Cardiol. 2013 Oct 8;62(15):1320-7. doi: 10.1016/j.jacc.2013.05.079. Epub 2013 Jul 10.

引用本文的文献

1
Use of Oral Anticoagulation and Diabetes Do Not Inhibit the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes.口服抗凝药的使用和糖尿病不会抑制缺氧预处理的血液衍生分泌组的血管生成潜力。
Biomedicines. 2020 Aug 11;8(8):283. doi: 10.3390/biomedicines8080283.

本文引用的文献

1
Real-World Results of Supera Stent Implantation for Popliteal Artery Atherosclerotic Lesions: 3-Year Outcome.Supera支架植入治疗腘动脉粥样硬化病变的真实世界结果:3年随访结果
Ann Vasc Surg. 2020 Jan;62:397-405. doi: 10.1016/j.avsg.2019.06.038. Epub 2019 Aug 23.
2
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.2015 年全球、区域和国家外周动脉疾病的患病率和风险因素:更新的系统评价和分析。
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030. doi: 10.1016/S2214-109X(19)30255-4.
3
Vessel Calcification as a Risk Factor for In-Stent Restenosis in Complex Femoropopliteal Lesions After Zilver PTX Paclitaxel-Coated Stent Placement.
血管钙化是 Zilver PTX 紫杉醇涂层支架置入治疗复杂股腘动脉病变后支架内再狭窄的危险因素。
J Endovasc Ther. 2019 Oct;26(5):613-620. doi: 10.1177/1526602819860124. Epub 2019 Jul 1.
4
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.全球血管指南:慢性肢体威胁性缺血的管理。
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006. Epub 2019 Jun 8.
5
A Network Meta-analysis of Randomized Controlled Trials Comparing Treatment Modalities for Infrapopliteal Lesions in Critical Limb Ischemia.一项比较严重肢体缺血患者腘下病变治疗方式的随机对照试验的网络荟萃分析。
Ann Vasc Surg. 2019 Oct;60:424-434. doi: 10.1016/j.avsg.2019.02.021. Epub 2019 May 7.
6
Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.药物洗脱球囊血管成形术与未涂层球囊血管成形术治疗股腘动脉支架内再狭窄的比较。
Cochrane Database Syst Rev. 2019 Jan 26;1(1):CD012510. doi: 10.1002/14651858.CD012510.pub2.
7
Systematic review of endovascular intervention and surgery for common femoral artery atherosclerotic disease.系统评价腔内介入治疗与手术治疗股总动脉粥样硬化性疾病的效果。
Br J Surg. 2019 Jan;106(1):13-22. doi: 10.1002/bjs.11026.
8
Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.药物涂层球囊血管成形术治疗股腘段支架内再狭窄。
Circ Cardiovasc Interv. 2018 Dec;11(12):e007055. doi: 10.1161/CIRCINTERVENTIONS.118.007055.
9
Living a burdensome and demanding life: A qualitative systematic review of the patients experiences of peripheral arterial disease.过着负担沉重且要求苛刻的生活:一项定性系统评价外周动脉疾病患者的体验。
PLoS One. 2018 Nov 15;13(11):e0207456. doi: 10.1371/journal.pone.0207456. eCollection 2018.
10
Endovascular treatment for the common femoral artery: is there a challenger to open surgery?股总动脉的血管内治疗:开放手术是否面临挑战?
J Cardiovasc Surg (Torino). 2019 Feb;60(1):8-13. doi: 10.23736/S0021-9509.18.10787-7. Epub 2018 Nov 12.